Management of Australian Adults with Bronchiectasis in Tertiary Care: Evidence-Based or Access-Driven?
Visser SK, Bye PTP, Fox GJ, Burr LD, Chang AB, Holmes-Liew CL, King P, Middleton PG, Maguire GP, Smith D, Thomson RM, Stroil-Salama E, Britton WJ, Morgan LC.
Visser SK, et al. Among authors: bye ptp.
Lung. 2019 Dec;197(6):803-810. doi: 10.1007/s00408-019-00280-x. Epub 2019 Nov 5.
Lung. 2019.
PMID: 31691027
Despite guideline recommendations against routine use, inhaled corticosteroids were used in 48% of patients. Long-term macrolides were used in 28% of participants. CONCLUSIONS: Discrepancies exist between guideline recommendations and real-world treatment of bronchiectasis …
Despite guideline recommendations against routine use, inhaled corticosteroids were used in 48% of patients. Long-term macrolides wer …